The COVID-19 pandemic: New global challenges for the haemophilia community

Affiliations

¹ Hemostasis and Thrombosis Unit, Division of Hematology, Saint-Luc University Hospital, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
² World Federation of Hemophilia, Montreal, QC, Canada.

Editorial

Cedric Hermans et al. Haemophilia. 2020 May.

. 2020 May;26(3):371-372.

doi: 10.1111/hae.14001. Epub 2020 Apr 20.

¹ Hemostasis and Thrombosis Unit, Division of Hematology, Saint-Luc University Hospital, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
² World Federation of Hemophilia, Montreal, QC, Canada.

No abstract available

Comment on

A Novel Coronavirus from Patients with Pneumonia in China, 2019.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. Zhu N, et al. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24. N Engl J Med. 2020. PMID: 31978945 Free PMC article.

1. Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost. 2014;40(5):571-576.
1. Pasi KJ, Rangarajan S, Mitchell N, et al. Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A. N Engl J Med. 2020;382(1):29-40.
1. George LA, Sullivan SK, Giermasz A, et al. Hemophilia B gene therapy with a high-specific-activity factor IX variant. N Engl J Med. 2017;377(23):2215-2227.
1. Mannucci PM. Hemophilia therapy: the future has begun. Haematologica. 2020;105(3):545-553.
1. Hermans C, Brackmann HH, Schinco P, Auerswald G. The case for wider use of recombinant factor VIII concentrates. Crit Rev Oncol Hematol. 2012;83(1):11-20.